FreeStyle Libre 3 and Dexcom G7 represent the two most popular continuous glucose monitoring systems in 2025. Both eliminate fingerstick testing, provide real-time glucose data, and integrate with smartphones—but they differ significantly in accuracy, reliability, cost, and features.
This comprehensive head-to-head comparison examines accuracy (MARD), sensor reliability, customer support quality, insurance coverage, and real-world user experiences based on 2,164 verified reviews to help you choose the right CGM system.
Whether you prioritize accuracy, predictive alerts, data sharing with caregivers, or cost-effectiveness, this detailed analysis will guide you to the best CGM for your specific diabetes management needs.
What You'll Find in This Review
- Side-by-side feature comparison of Libre 3 and Dexcom G7 systems
- Accuracy analysis from independent clinical studies (7.8% vs 8.2% MARD)
- Reliability assessment based on 2,164 verified user reviews
- Total cost breakdown including insurance scenarios
Detailed Reviews
In-depth analysis of each supplement
FreeStyle Libre 3
Better Accuracy, Lower Cost, But Reliability Concerns

Key Ingredients
Key Benefits
- Better accuracy: 7.8% MARD vs Dexcom's 8.2%
- Longer sensor life: 14 days vs 10 days
- Faster warm-up: 60 minutes vs 30 minutes for G7
- Lower cost: $2,080/year vs $3,000/year
- Smaller, more discreet sensor
- Real-time glucose readings every minute
- Broader insurance coverage in many plans
Considerations
- Only 1 in 4 sensors lasts full 14 days (user reports)
- Frequent sensor failures and adhesive problems
- Dangerous false readings reported (40 when actually 251)
- Poor customer service response times
- No predictive low glucose alerts
- Limited data sharing capabilities
- Expensive replacements (£50+ per sensor)
Dexcom G7
Advanced Features & Data Sharing, But Sensor Failures

Key Ingredients
Key Benefits
- Fastest warm-up: 30 minutes vs 60 for Libre
- Predictive alerts: 20-minute warning before lows
- Excellent data sharing: 10 followers vs Libre's limited sharing
- Apple Watch integration
- Compatible with insulin pumps (closed-loop systems)
- More advanced app features and pattern recognition
- Better integration with diabetes management platforms
Considerations
- Lower accuracy: 8.2% MARD vs Libre's 7.8%
- Sensors fail at 7-8 days (not full 10 days advertised)
- 1 in 3 sensors falls off due to adhesive failure
- Terrible customer service (hours-long hold times)
- Recent product recalls with unreachable support
- Higher cost: $3,000/year vs $2,080 for Libre
- Inaccurate readings and false low alerts
The Verdict
It Depends on Your Priorities

Key Ingredients
Key Benefits
- Both offer massive improvement over fingerstick-only testing
- Both provide real-time glucose data and trends
- Both eliminate routine fingerstick calibrations
- Both integrate with smartphones for data tracking
- Both covered by many insurance plans (with authorization)
Considerations
- Both systems suffer from significant sensor reliability issues
- Both have poor customer service ratings (1.2-1.3 stars)
- Both require backup fingerstick meters for safety
- Both face frequent complaints about early sensor failures
- Both have expensive replacement costs when sensors fail
Side-by-Side Comparison
Compare key features across all supplements
MARD Accuracy
Sensor Duration
Warm-Up Time
Reading Frequency
Annual Cost
Predictive Alerts
Data Sharing
Pump Integration
User Rating
Sensor Reliability
Customer Service
Common Questions
Quick answers to help you decide
User Experiences
Hear from actual supplement users
“The predictive alerts are genuinely lifesaving for my Type 1 diabetes. Sharing data with my wife gives us peace of mind. BUT: Sensors fail at 7-8 days constantly. Customer service puts you on hold for hours. One out of three sensors just falls off. Frustrating and expensive.”
“Both systems represent significant advances in diabetes technology, but reliability issues are real. I always tell patients to maintain a backup fingerstick meter. Choose based on features needed: Libre for accuracy and cost, Dexcom for alerts and sharing. Neither is perfect—yet.”
The Bottom Line
Both FreeStyle Libre 3 and Dexcom G7 offer revolutionary continuous glucose monitoring, but neither system is without significant compromises. The choice depends on your specific priorities and diabetes management needs.
Choose FreeStyle Libre 3 if you prioritize: highest accuracy (7.8% MARD), lowest cost ($2,080/year), longer sensor wear (14 days), and have good insurance coverage for Abbott products. Accept that you'll need to manage occasional sensor failures and keep backup supplies.
Choose Dexcom G7 if you need: predictive low glucose alerts, robust data sharing with 10 followers, insulin pump integration (closed-loop), fastest warm-up (30 minutes), and advanced app features. Prepare for higher costs ($3,000/year) and similar reliability challenges.
Critical for both systems: Always maintain a backup fingerstick meter. User ratings (1.2-1.3 stars) reflect genuine reliability and customer service issues. Budget for occasional sensor failures and have a plan for replacement delays. CGM technology is excellent—execution and support need improvement.